European Archives - Page 852 of 1057 - European Medical Journal

EMJ

The Clinical Use of ASV – What Have We Learned Lately?

Anita Simonds explains the latest clinical evidences about ASV.

EMJ

What’s Happened and Where next for ASV? In Heart Failure and Out of Heart Failure

Anita Simonds explains the latest clinical evidences about ASV in Heart Failure.

EMJ

Other Key Areas of Interest for ASV, Complex Sleep Apnea and Treatment Emergent CSA: CSA in Non-Cardiac Patients; Opioid Induced SDB

Anita Simonds explains the usage of ASV in the other areas of interest of Heart Failure.

EMJ

Clinical Case of Sleep Disordered Breathing in a Patient with Heart Failure and Reduced Ejection Fraction (HFrEF)

Michael Arzt presents a clinical case of ASV in the SERVE-HF population.

EMJ

Clinical Case of ASV in a Patient with Opioids Induced Central Sleep Apnea

Michael Arzt presents a clinical case of ASV in opioid induced CSA.

EMJ

Clinical Case of ASV in a Patient with Heart Failure and Preserved Ejection Fraction

Michael Arzt presents a clinical case of ASV in HFpEF.

EMJ

Management of SDB with Adaptive Servo Ventilation

Symposium at the Sleep&Breathing meeting in April 2017 in Marseille (France).

RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis

Tel-Aviv, Israel, Raleigh, USA, 14 June, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…

Acarix Receives First Commercial Order for CADScor®System for Early Detection of Coronary Artery Disease from Danish Hospital

Malmö, Sweden, 13 June, 2017 – Acarix AB (publ) (“Acarix” or the “Company”) today announced that Herning Hospital has placed the first commercial order…

New LEADER Analysis Shows Victoza® Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events

New LEADER analysis shows Victoza® reduces cardiovascular risk in people with Type 2 Diabetes regardless of severe hypoglycaemia events.